When some US states allowed nurse practitioners to prescribe controlled substances without physician oversight, a serious unintended consequence took hold: Doctors found themselves competing with those nurses for patients. Molly Schnell, BFI Saieh Family Fellow and assistant professor at Northwestern University, along with her colleagues—Janet Currie of Princeton and Anran Li of Cornell—examine the resultant uptick in prescriptions in controlled substances, and the impact on patients.